SRTA
NASDAQStrata Critical Medical Inc.
News25/Ratings3
News · 26 weeks53-64%
2025-10-262026-04-19
Mix2090d
- Insider8(40%)
- SEC Filings5(25%)
- Earnings3(15%)
- Analyst2(10%)
- Offering1(5%)
- Other1(5%)
Latest news
25 items- PRStrata Critical Medical Schedules First Quarter 2026 Earnings Conference CallNEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical. (NASDAQ:SRTA, "Strata" or the "Company")), will release financial results for the first quarter ended March 31, 2026 on Wednesday May 6, 2026 before the market opens. The company will hold a conference call on the same day at 8:00 am Eastern Time to discuss the results. The call will be hosted by Melissa Tomkiel, Strata's Co-Chief Executive Officer and General Counsel, and Will Heyburn, Strata's Co-Chief Executive Officer and Chief Financial Officer, and will include a question-and-answer session for call participants. To join the live call, please register here. Upon registration, a dial-in and unique PIN will be provi
- SECSEC Form DEFA14A filed by Strata Critical Medical Inc.DEFA14A - Strata Critical Medical, Inc. (0001779128) (Filer)
- SECSEC Form DEF 14A filed by Strata Critical Medical Inc.DEF 14A - Strata Critical Medical, Inc. (0001779128) (Filer)
- PRStrata Critical Medical to Present at the 25th Annual Needham Virtual Healthcare ConferenceNEW YORK, April 09, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (NASDAQ:SRTA, "Strata" or the "Company")), today announced that management will present at the 25th Annual Needham Virtual Healthcare Conference on Wednesday, April 15, 2026, at 1:30 pm ET. A webcast of the event will be available at the link here. A replay will be available shortly after the conclusion of the presentation on the investor relations section of the Company's website at https://ir.stratacritical.com/. About Strata Critical Medical Strata Critical Medical provides time-critical logistics solutions and specialized medical services to healthcare providers across the United States, strategically expandi
- ANALYSTCraig Hallum initiated coverage on Strata Critical Medical with a new price targetCraig Hallum initiated coverage of Strata Critical Medical with a rating of Buy and set a new price target of $8.00
- ANALYSTB. Riley Securities initiated coverage on Strata Critical Medical with a new price targetB. Riley Securities initiated coverage of Strata Critical Medical with a rating of Buy and set a new price target of $8.00
- INSIDERAmendment: SEC Form 4 filed by Cohen Amir4/A - Strata Critical Medical, Inc. (0001779128) (Issuer)
- INSIDERSEC Form 4 filed by Wunsch Scott M4 - Strata Critical Medical, Inc. (0001779128) (Issuer)
- INSIDERSEC Form 4 filed by Strata Critical Medical Inc.4 - Strata Critical Medical, Inc. (0001779128) (Issuer)
- INSIDERSEC Form 4 filed by Strata Critical Medical Inc.4 - Strata Critical Medical, Inc. (0001779128) (Issuer)
- INSIDERCEO, Trinity Air Medical Wunsch Scott M covered exercise/tax liability with 3,631 shares, decreasing direct ownership by 0.63% to 569,807 units (SEC Form 4)4 - Strata Critical Medical, Inc. (0001779128) (Issuer)
- INSIDERSEC Form 4 filed by Strata Critical Medical Inc.4 - Strata Critical Medical, Inc. (0001779128) (Issuer)
- SECSEC Form 10-K filed by Strata Critical Medical Inc.10-K - Strata Critical Medical, Inc. (0001779128) (Filer)
- SECStrata Critical Medical Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Strata Critical Medical, Inc. (0001779128) (Filer)
- PRStrata Critical Medical Announces Fourth Quarter 2025 ResultsRevenue increased 83.5% year-over-year to $66.8 million in Q4 2025Logistics revenue and gross profit grew 35.3% and 39.5% year-over-year, respectively, in Q4 2025, which represents Strata's organic growthFull year 2025 net loss from continuing operations was $20.1 millionFull year 2025 revenue and Adjusted EBITDA(1) of $197.1 million and $14.1 million, respectively, both beat the high end of our guidance rangeRaising full year 2026 revenue guidance to between $260 and $275 million and Adjusted EBITDA guidance to between $29 and $33 million(2) NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (NASDAQ:SRTA, ", Strata", or the ", Company", )), today announced financi
- INSIDERChief Accounting Officer Cohen Amir was granted 64,191 shares, increasing direct ownership by 55% to 181,817 units (SEC Form 4)4 - Strata Critical Medical, Inc. (0001779128) (Issuer)
- INSIDERCEO, Trinity Air Medical Wunsch Scott M was granted 51,353 shares, increasing direct ownership by 10% to 573,438 units (SEC Form 4)4 - Strata Critical Medical, Inc. (0001779128) (Issuer)
- PRStrata Critical Medical Schedules Fourth Quarter 2025 Earnings Conference CallNEW YORK, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical (NASDAQ:SRTA, "Strata" or the "Company")), will release financial results for the fourth quarter ended December 31, 2025 on Tuesday, March 3, 2026 before the market opens. The company will hold a conference call on the same day at 8:00 am Eastern Time to discuss the results. The call will be hosted by Will Heyburn, Strata's Co-Chief Executive Officer and Chief Financial Officer, and Melissa Tomkiel, Strata's Co-Chief Executive Officer and General Counsel, and will include a question-and-answer session for call participants. To join the live call, please register here. Upon registration, a dial-in and unique PIN will be pr
- SECStrata Critical Medical Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Strata Critical Medical, Inc. (0001779128) (Filer)
- PRStrata Announces Closing of Revolving Credit Facility to Support Acquisition Strategy Execution$30 million ABL Facility will support future acquisitions and be undrawn at close; can be increased to $50 million, subject to certain conditionsOwned aircraft excluded from collateral package and remain unencumbered NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (NASDAQ:SRTA, "Strata" or the "Company")), a leading provider of logistics and medical services in the organ transplant industry, today announced that the Company has entered into a credit agreement with JPMorgan Chase Bank, N.A. for secured, asset-based revolving credit loans in aggregate principal amount of up to $30.0 million, which, subject to certain conditions, may be increased up to an aggregate
- INSIDERWunsch Scott M increased direct ownership by 78% to 522,085 units (SEC Form 5)5 - Strata Critical Medical, Inc. (0001779128) (Issuer)
- INSIDERCo-CEO and General Counsel Tomkiel Melissa M. exercised 276,960 shares at a strike of $0.18, increasing direct ownership by 20% to 1,643,362 units (SEC Form 4)4 - Strata Critical Medical, Inc. (0001779128) (Issuer)
- INSIDERCo-CEO and General Counsel Tomkiel Melissa M. covered exercise/tax liability with 34,018 shares, decreasing direct ownership by 2% to 1,366,402 units (SEC Form 4)4 - Strata Critical Medical, Inc. (0001779128) (Issuer)
- INSIDERCo-CEO and CFO Heyburn William A. covered exercise/tax liability with 35,348 shares, decreasing direct ownership by 3% to 1,368,088 units (SEC Form 4)4 - Strata Critical Medical, Inc. (0001779128) (Issuer)
- INSIDERChief Accounting Officer Cohen Amir covered exercise/tax liability with 3,716 shares, decreasing direct ownership by 3% to 117,626 units (SEC Form 4)4 - Strata Critical Medical, Inc. (0001779128) (Issuer)